[Oral therapy of nasal sinus diseases with a new drug compound].
D000293:Adolescent; D000328:Adult; D000605:Amino Alcohols / Q000627:therapeutic use*; D001532:Atropa belladonna / Q000627:therapeutic use*; D002648:Child; D002744:Chlorpheniramine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010256:Paranasal Sinuses; D010627:Phenethylamines / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D000605:Amino Alcohols; D010627:Phenethylamines; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D002744:Chlorpheniramine
O tratamento das afeções naso-sinusais com uma nova associação medicamentosa por via oral.